FDAnews
www.fdanews.com/articles/137850-st-jude-medical-reveals-randomized-clinical-trial-data-demonstrating-benefit-of-neuromodulation-for-chronic-migraine

St. Jude Medical Reveals Randomized Clinical Trial Data Demonstrating Benefit of Neuromodulation for Chronic Migraine

June 23, 2011
St. Jude Medical, Inc., a global medical device company, announced Thursday study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide.
MarketWatch